82_FR_45791 82 FR 45603 - National Human Genome Research Institute; Notice of Closed Meeting

82 FR 45603 - National Human Genome Research Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 188 (September 29, 2017)

Page Range45603-45603
FR Document2017-20988

Federal Register, Volume 82 Issue 188 (Friday, September 29, 2017) 
[Federal Register Volume 82, Number 188 (Friday, September 29, 2017)]
[Notices]
[Page 45603]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-20988]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Inherited Disease Research Access 
Committee.
    Date: November 9, 2017.
    Time: 11:30 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 3049, 5635 Fishers Lane, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Barbara J. Thomas, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Human Genome Research 
Institute, National Institutes of Health, 5635 Fishers Lane, Ste. 
4076, MSC 9306, Bethesda, MD 20892-9306, 301-402-0838, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)


    Dated: September 26, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-20988 Filed 9-28-17; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices 45603 ESTIMATED ANNUALIZED BURDEN HOURS Average Number of Number of burden per Total annual Type of respondents responses per respondents response burden hours respondent (in hours) Investigators ................................................................................................... 3,120 1 25/60 1,300 Returning Investigators to update information .............................................. 1,000 1 15/60 250 Total ........................................................................................................ 4,120 4,120 ........................ 1,550 Dated: September 24, 2017. Dated: September 25, 2017. DEPARTMENT OF HEALTH AND Lawrence A. Tabak, David Clary, HUMAN SERVICES Principal Deputy Director, National Institutes Program Analyst, Office of Federal Advisory of Health. Committee Policy. National Institutes of Health [FR Doc. 2017–20885 Filed 9–28–17; 8:45 am] [FR Doc. 2017–20859 Filed 9–28–17; 8:45 am] BILLING CODE 4140–01–P National Institute of Diabetes and BILLING CODE 4140–01–P Digestive and Kidney Diseases; Notice of Closed Meetings DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Advisory Committee Act, as HUMAN SERVICES amended, notice is hereby given of the National Institutes of Health National Institutes of Health following meetings. National Human Genome Research The meetings will be closed to the National Institute on Minority Health Institute; Notice of Closed Meeting public in accordance with the and Health Disparities; Notice of provisions set forth in sections Closed Meeting Pursuant to section 10(d) of the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Federal Advisory Committee Act, as as amended. The grant applications and Pursuant to section 10(d) of the amended, notice is hereby given of the the discussions could disclose Federal Advisory Committee Act, as following meeting. confidential trade secrets or commercial amended, notice is hereby given of the The meeting will be closed to the property such as patentable material, following meeting. public in accordance with the and personal information concerning provisions set forth in sections individuals associated with the grant The meeting will be closed to the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications, the disclosure of which public in accordance with the as amended. The grant applications and would constitute a clearly unwarranted provisions set forth in sections the discussions could disclose invasion of personal privacy. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., confidential trade secrets or commercial as amended. The grant applications and Name of Committee: National Institute of property such as patentable material, Diabetes and Digestive and Kidney Diseases the discussions could disclose and personal information concerning Special Emphasis Panel; Planning NIDDK confidential trade secrets or commercial individuals associated with the grant Clinical Trials. property such as patentable materials, applications, the disclosure of which Date: November 9, 2017. and personal information concerning would constitute a clearly unwarranted Time: 9:00 a.m. to 10:30 a.m. individuals associated with the grant invasion of personal privacy. Agenda: To review and evaluate grant applications, the disclosure of which applications. Name of Committee: Center for Inherited Place: National Institutes of Health, Two would constitute a clearly unwarranted Disease Research Access Committee. Democracy Plaza, 6707 Democracy invasion of personal privacy. Date: November 9, 2017. Boulevard, Bethesda, MD 20892 (Telephone Time: 11:30 a.m. to 1:30 p.m. Conference Call). Name of Committee: National Institute on Agenda: To review and evaluate grant Minority Health and Health Disparities Contact Person: Elena Sanovich, Ph.D., applications. Scientific Review Officer, Review Branch, Special Emphasis Panel; ZMD1 DRI (J1) NIH Place: National Institutes of Health, 3049, DEA, NIDDK, National Institutes of Health, Support for Conferences and Scientific 5635 Fishers Lane, Bethesda, MD 20892 Room 7351, 6707 Democracy Boulevard, Meetings (Parent R13). (Telephone Conference Call). Bethesda, MD 20892–2542, 301–594–8886, Date: October 23, 2017. Contact Person: Barbara J. Thomas, Ph.D., sanoviche@mail.nih.gov. Time: 12:00 p.m. to 5:00 p.m. Scientific Review Officer, Scientific Review Branch, National Human Genome Research Name of Committee: National Institute of Agenda: To review and evaluate grant Institute, National Institutes of Health, 5635 Diabetes and Digestive and Kidney Diseases applications. Fishers Lane, Ste. 4076, MSC 9306, Bethesda, Special Emphasis Panel; NIDDK Program Place: National Institutes of Health, MD 20892–9306, 301–402–0838, Project (P01). Gateway Plaza, 533, 7201 Wisconsin Avenue, barbara.thomas@nih.gov. Date: November 14, 2017. Suite 533, Bethesda, MD 20814 (Catalogue of Federal Domestic Assistance Time: 1:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant asabaliauskas on DSKBBXCHB2PROD with NOTICES (Telepresence). Program Nos. 93.172, Human Genome Contact Person: Deborah Ismond, Ph.D., Research, National Institutes of Health, HHS) applications. Scientific Review Officer, Division of Place: National Institutes of Health, Two Dated: September 26, 2017. Democracy Plaza, 6707 Democracy Scientific Programs, National Institute on Sylvia L. Neal, Boulevard, Bethesda, MD 20892 (Telephone Minority Health and Health Disparities, Conference Call). National Institutes of Health, 7201 Wisconsin Program Analyst, Office of Federal Advisory Contact Person: Jason D. Hoffert, Ph.D., Ave., Suite 525, Bethesda, MD 20814, (301) Committee Policy. Scientific Review Officer, Review Branch, 594–2704, ismonddr@mail.nih.gov. [FR Doc. 2017–20988 Filed 9–28–17; 8:45 am] DEA, NIDDK, National Institutes of Health, BILLING CODE 4140–01–P Room 7343, 6707 Democracy Boulevard, VerDate Sep<11>2014 18:50 Sep 28, 2017 Jkt 241001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\29SEN1.SGM 29SEN1


Document Created: 2017-09-29 03:27:17
Document Modified: 2017-09-29 03:27:17
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 9, 2017.
FR Citation82 FR 45603 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR